Stockscreener 앱 받기
416.30
1.54%
6.32
시간 외 거래:
416.30
전일 마감가:
$409.98
열려 있는:
$412.31
하루 거래량:
1.22M
Relative Volume:
0.78
시가총액:
$93.50B
수익:
$183.12B
순이익/손실:
$5.92B
주가수익비율:
16.24
EPS:
25.63
순현금흐름:
$3.67B
1주 성능:
+0.60%
1개월 성능:
-2.94%
6개월 성능:
-0.35%
1년 성능:
-21.00%
1일 변동 폭
$408.00
$417.92
1주일 범위
$406.55
$422.68
52주 변동 폭
$362.21
$567.26
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
416.30 | 93.50B | 183.12B | 5.92B | 3.67B | 25.63 |
|
UNH
Unitedhealth Group Inc
|
404.81 | 382.29B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
333.01 | 90.33B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.10 | 81.97B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
256.69 | 31.77B | 117.76B | 1.21B | 2.39B | 9.95 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Humana, Elevance, Aetna Face DOJ Lawsuit Over Illegal Kickback Scheme, Discrimination Against Disabled People - Benzinga
Investors Met With Slowing Returns on Capital At Elevance Health (NYSE:ELV) - Yahoo Finance
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today - Benzinga
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks - Yahoo Finance
DOJ accuses health insurance giants of role in Medicare kickback scheme - Cleveland.com
Justice Department hits Aetna, Humana, Elevance Health with Medicare Advantage kickback complaint - Fierce Healthcare
Elevance Health Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
Inova and Anthem Announce New Contract for Virginians - Business Wire
Elevance Health, Inc. (ELV): Among the Best Stocks to Buy According to D1 Capital’s Daniel Sundheim - Insider Monkey
Elevance Curbs Online Medicare Sign-Ups as Expenses Rise (ELV) - Bloomberg
Mental health network misled policyholders about provider options, lawsuit claims - Reuters
Elevance Nurses Say Their Right To OT Is Beyond Dispute - Law360
Let’s talk tariffs, and no Amazon Prime subscription with your MA plan - statnews.com
Elevance Health to slash Medicare Advantage marketing - Modern Healthcare
Is Elevance (ELV) an Attractively Valued Stock? - MSN
Elevance Health’s MLR Beat Encourages Worried Wall Street - AIS Health
Argus Adjusts Price Target on Elevance Health to $465 From $450 - marketscreener.com
‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock - markets.businessinsider.com
Elevance Health (ELV) Gets a Buy from Barclays - The Globe and Mail
Elevance Health: Carelon Growth, Not Fully Appreciated (NYSE:ELV) - Seeking Alpha
Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion - MSN
Deutsche Bank Cuts Elevance Health Price Target to $463 From $465, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $488 From $461, Maintains Buy Rating - marketscreener.com
Cantor maintains Elevance stock with $485 target, Overweight rating - Investing.com
Why Elevance Health, Inc. (ELV) is Among the Best Stocks That Will Always Grow - Yahoo Finance
Elevance Health (ELV) Maintains Dividend, Affirms 2025 Outlook - GuruFocus
Elevance Health Inc. (NYSE:ELV) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Increases Price Target for Elevance Health (ELV) to $52 - GuruFocus
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... - Yahoo Finance
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Expansions - GuruFocus
Elevance Health: Q1 Earnings Snapshot - CT Insider
Elevance Health Reports Strong Q1 2025 Results - TipRanks
Elevance dodges high MA medical costs that sunk United - Healthcare Brew
Elevance Health Q1 2025 Earnings Call Highlights - TipRanks
Despite Medicaid pressures, Elevance reports strong Q1 earnings - InsuranceNewsNet
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Elevance Health execs seek to ease Wall Street's concerns about elevated MA costs - Fierce Healthcare
Elevance Health (ELV) Q1 2025 Earnings Report Highlights Growth - GuruFocus
Elevance Health Inc (ELV) Shares Down 4.72% on Apr 21 - GuruFocus
Barclays Adjusts Elevance Health Price Target to $522 From $512, Keeps Overweight Rating - marketscreener.com
Elevance says healthcare demand tracks expectations after UnitedHealth's forecast cut - marketscreener.com
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook - Yahoo Finance
Elevance Health beats Q1 expectations, reaffirms 2025 outlook - Investing.com
Elevance reports lower-than-expected medical costs, confirms profit beat - Reuters
Earnings call transcript: Elevance Health Q1 2025 beats EPS forecast - Investing.com
Is Elevance Health (ELV) The Top Falling Stock with Unusual Volume? - MSN
Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elevance sees lower-than-expected medical costs in Q1 - Modern Healthcare
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.50%
자본화:
|
볼륨(24시간):